CN108977365B - Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues - Google Patents
Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues Download PDFInfo
- Publication number
- CN108977365B CN108977365B CN201810930453.2A CN201810930453A CN108977365B CN 108977365 B CN108977365 B CN 108977365B CN 201810930453 A CN201810930453 A CN 201810930453A CN 108977365 B CN108977365 B CN 108977365B
- Authority
- CN
- China
- Prior art keywords
- lincomycin
- fermentation
- penicillium oxalicum
- residues
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 46
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title claims abstract description 44
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 229960005287 lincomycin Drugs 0.000 title claims abstract description 41
- 241000985513 Penicillium oxalicum Species 0.000 title claims abstract description 28
- 230000015556 catabolic process Effects 0.000 title claims abstract description 15
- 238000006731 degradation reaction Methods 0.000 title claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims abstract description 32
- 230000004151 fermentation Effects 0.000 claims abstract description 30
- 238000012258 culturing Methods 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000000593 degrading effect Effects 0.000 claims abstract description 5
- 239000001963 growth medium Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 229920001817 Agar Polymers 0.000 claims description 15
- 239000008272 agar Substances 0.000 claims description 15
- 239000002609 medium Substances 0.000 claims description 15
- 244000061456 Solanum tuberosum Species 0.000 claims description 14
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000001888 Peptone Substances 0.000 claims description 13
- 108010080698 Peptones Proteins 0.000 claims description 13
- 235000019319 peptone Nutrition 0.000 claims description 13
- 235000015278 beef Nutrition 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000011218 seed culture Methods 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 6
- 238000009629 microbiological culture Methods 0.000 claims description 3
- 241001052560 Thallis Species 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 4
- 230000003115 biocidal effect Effects 0.000 description 26
- 241000233866 Fungi Species 0.000 description 16
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 13
- 239000003242 anti bacterial agent Substances 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000009631 Broth culture Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108020004566 Transfer RNA Proteins 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000009264 composting Methods 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000010865 sewage Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000228150 Penicillium chrysogenum Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002921 fermentation waste Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002910 solid waste Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 108020000949 Fungal DNA Proteins 0.000 description 1
- 244000168141 Geotrichum candidum Species 0.000 description 1
- 235000017388 Geotrichum candidum Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/80—Penicillium
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
Abstract
The invention discloses a penicillium oxalicum L5 and application thereof in degrading lincomycin bacterial residues, wherein the application method comprises the following steps: and (3) inoculating fermentation liquor obtained by fermenting and culturing penicillium oxalicum L5 into lincomycin bacterial residues, and culturing at 25-37 ℃ and 80-220rpm to realize bacterial residue degradation. The penicillium oxalicum L5 can be used for directly decomposing lincomycin bacterial residues, the consumption rate of the lincomycin bacterial residues for six days reaches 88.20%, and the harm of the bacterial residues to the ecological environment and the human health is reduced.
Description
Technical Field
The invention relates to a strain and a method for harmlessly treating lincomycin bacterial residues, in particular to a strain which is treated and then recycled, and belongs to the field of environmental protection.
Background
China is a big antibiotic producing country, the annual production of main antibiotics exceeds 14 million tons, and the annual production of solid wastes (mycelium and protein), namely antibiotic fungi residues, produced in the antibiotic producing process exceeds 140 million tons.
The antibiotic residues are solid fermentation wastes generated in the process of producing antibiotics by fermentation, the main components of the antibiotic residues are mycelium of antibiotic producing bacteria, unused culture medium, metabolites generated in the fermentation process, degradation products of the culture medium, a small amount of antibiotics and the like, the antibiotic residues are special dangerous wastes, and if the antibiotic residues are not properly treated, the antibiotic residues can generate potential hazards to the ecological environment and the human health, and the hazards have the characteristics of concealment, hysteresis, accumulation, cooperativity, continuity and the like.
The antibiotic residues contain a small amount of residual antibiotics and degradation products thereof, so that the antibiotic residues are potentially harmful to the ecological environment. The environmental ecosystem is composed of different species of biota in the form of a food chain. The long-term low-dose intake of antibiotics by food animals such as livestock and poultry can cause the livestock and poultry to generate drug resistance to the antibiotics, and meanwhile, the antibiotics accumulate in the bodies of the animals to cause the antibiotic residues in meat, eggs, milk and internal organs of the animal food. Antibiotics in animal food are transmitted to people along a food chain, on one hand, allergic reaction of people can be caused, and in severe cases, food poisoning of people can be caused; some medicines also have the effects of carcinogenesis, teratogenesis, mutagenesis and the like, and seriously interfere various physiological functions of human beings. On the other hand, animal food containing antibiotics can have adverse effects on normal flora in intestinal tracts of human bodies, destroy balance of ecosystem in the intestinal tracts and enable pathogenic bacteria to propagate in a large quantity; but also can transfer drug-resistant bacteria in animals to human beings, thus threatening human health. Meanwhile, the organic matter content of the fungus dregs is high, secondary fermentation can be caused, the color becomes black, foul smell is generated, and the environment is seriously influenced.
The antibiotic fungi residues are treated according to dangerous waste and prohibited to be used for producing feed according to the regulation of pharmaceutical industry pollution prevention and treatment technical policy (No. 18 in 2012) in China. Aiming at the problems of large production amount and large treatment difficulty of antibiotic fungi residues and the policy suggestion of ' encouraging the development of reuse technology, harmless treatment technology and comprehensive utilization technology of fermented fungi residues in the production process ' in the technical policy of pollution prevention and control in pharmaceutical industry ', an economic, efficient and large-treatment-capacity method is sought, so that the reasonable and effective utilization and safe treatment of the antibiotic fungi residues are realized, and the method has important significance.
The current treatment and disposal technologies for antibiotic fungi residues comprise incineration, composting, forage (prohibited), landfill, energy regeneration (anaerobic fermentation for producing methane) and other treatment and disposal technologies. The main composition of the mushroom dregs is water, a large amount of energy is consumed for drying the mushroom dregs, and the heat value of the mushroom dregs is not high; many antibiotic fungi residues contain more elements such as sulfur, nitrogen and the like, and increase the desulfurization burden of a boiler and the pollution of oxynitride during combustion. The possible problem of antibiotic residues renders the composting unacceptable to the public. Because of the shortage of land, landfill is not a long-term measure. The complexity of the components of the antibiotic fungi residues increases the difficulty of solid fermentation; the residual antibiotics in the mushroom dregs inhibit the growth of the microorganisms for fermentation; the fungus dregs are decomposed quickly, the solid fermentation time is long, the odor is serious in the fermentation process, and secondary pollution is generated. The mushroom dregs are used as a fermentation nitrogen source, which is another resource-recycling idea.
The residual antibiotic in the mushroom residue inhibits the growth of microorganisms, and therefore, degrades this to facilitate subsequent use thereof. There are two reports on lincomycin degradation: the degradation rate of the clostridium strain is 62.03 percent for 100 mg/L lincomycin after the clostridium strain is cultured with the mushroom dregs for 10 days, and the degradation rate is only 15.61 percent if the initial concentration is 500 mg/L; after the geotrichum candidum and the mushroom dregs are cultured for 10 days, the degradation rate of the lincomycin is 37%.
The antibiotic fermentation waste residues have potential hazard to the ecological environment due to a small amount of residual antibiotics and degradation products thereof, and have been regarded as one of the main public hazards of antibiotic production by the international society. Aiming at the problems of large production amount and large treatment difficulty of antibiotic fungi residues and the policy suggestion of ' encouraging the development of reuse technology, harmless treatment technology and comprehensive utilization technology of fermented fungi residues in the production process ' in the technical policy of pollution prevention and control in pharmaceutical industry ', an economic, efficient and large-treatment-capacity method is sought, so that the reasonable and effective utilization and safe treatment of the antibiotic fungi residues are realized, and the method has important significance.
At present, common treatment technologies for antibiotic bacteria residues comprise incineration, fertilizer formation (composting), landfill, energy regeneration (anaerobic fermentation for producing methane) and other treatment technologies, which have the defects.
Disclosure of Invention
The present invention provides a new bacterial strain-penicillium oxalicum (B) for degrading lincomycin bacterial dregsPenicillium oxalicum) L5 and application thereof in harmless degradation of lincomycin bacterial residues.
The specific technical scheme of the invention is as follows:
in a first aspect, the invention provides a novel strainStrain-penicillium oxalicum (B)Penicillium oxalicum) L5, deposited in China general microbiological culture Collection center, with the date of 2018, 4 and 8 months, the preservation number CGMCC No.15400, and No. 3, Xilu No.1, North Chen, of the Chaojing area, Beijing, the address.
In a second aspect, the invention provides an application of penicillium oxalicum L5 in degradation of lincomycin bacterial residues, and the application method comprises the following steps: and (3) inoculating fermentation liquor obtained by fermenting and culturing penicillium oxalicum L5 into lincomycin bacterial residues, and culturing at 25-37 ℃ (preferably 28 ℃) to realize bacterial residue degradation.
Further, the volume usage amount of the fermentation liquid is 0.1-10 mL/g, preferably 0.5mL/g, based on the weight of the lincomycin bacterial residues; the content of mycelia in the fermentation liquid is 1-5 g/mL, and 3.5g/mL is preferred.
Further, the fermentation liquor is prepared by the following method: inoculating penicillium oxalicum L5 to a potato culture medium (namely a fermentation culture medium), and carrying out fermentation culture at 20-37 ℃ and 80-220 r/min for 36-54 h (preferably 28 ℃, 200 r/min and 48 h); the potato culture medium comprises the following components: 200 g/L of potato, 20 g/L of glucose, 20 g/L of agar and deionized water as a solvent, and the pH value is natural.
Further, before fermentation, the penicillium oxalicum L5 is subjected to slant culture and seed culture, and then the seed solution is inoculated to a fermentation medium in an inoculum size of 2-10% (preferably 10%) by volume: inoculating penicillium oxalicum L5 to a slant culture medium, and culturing at 20-37 ℃ for 12-72 h (preferably at 37 ℃ for 48 h) to obtain slant bacteria; the final concentration of the slant culture medium comprises the following components by mass: 0.5-2% of glucose, 0.2-2% of peptone, 0.1-2% of beef extract, 0.1-2% of sodium chloride and 2% of agar, wherein the solvent is distilled water, and the pH value is 6-7.5; inoculating the slant thalli to a seed culture medium, and culturing at 20-37 ℃ and 80-220 r/min for 12-72 h (preferably culturing at 37 ℃ and 180 r/min for 48 h) to obtain a seed solution; the final concentration of the seed culture medium is as follows: 0.5-2% of glucose, 0.2-2% of peptone, 0.1-2% of beef extract, 0.5-2% of sodium chloride and distilled water as a solvent, wherein the pH value is 6-7.5.
Further, the final concentration composition of the slant medium (i.e., common broth agar medium): 0.5 percent of glucose, 1 percent of peptone, 0.1 percent of beef extract, 0.5 percent of NaCl, 2 percent of agar and distilled water as a solvent, and the pH value is 7.3-7.5.
Further, the final concentration composition of the seed medium (i.e., common broth medium): 0.5 percent of glucose, 1 percent of peptone, 0.1 percent of beef extract, 0.5 percent of NaCl and a solvent of distilled water, wherein the pH value is 7.3-7.5.
Furthermore, the lincomycin content in the lincomycin bacterial residues is 5-20 mg/g, and the lincomycin bacterial residues are mainly from Henan Tianfang pharmaceutical industry Co.
In the process of degrading the lincomycin bacterial residues, the lincomycin bacterial residues can be degraded in a mode of supplementing materials and adding the lincomycin bacterial residues, and the same amount of the lincomycin bacterial residues are added after the lincomycin bacterial residues are degraded, and the lincomycin bacterial residues can be added for 5 times at most.
Compared with the prior art, the invention has the following beneficial effects:
the invention provides a method for degrading lincomycin bacterial residues, which mainly utilizes penicillium oxalicum (penicillium oxalicum)) (Penicillium oxalicum) L5, can be used for directly dissolving lincomycin bacterial residues, has a consumption rate of 88.20 percent for six days, and reduces the harm of the bacterial residues to the ecological environment and the human health. We have found for the first time microorganisms that can directly degrade antibiotic residues, and such reports have not been seen before.
Drawings
FIG. 1 is a growth curve of the strain.
FIG. 2 shows the change curve of the degradation amount of lincomycin bacterial residues.
Detailed Description
For better illustration of the present invention, the following specific examples are given, but the scope of the present invention is not limited thereto.
The quality final concentration composition of a common broth culture medium is as follows: 0.5% of glucose, 1% of peptone, 0.1% of beef extract, 0.5% of sodium chloride and deionized water as a solvent, wherein the pH value is 7.4 +/-0.1.
The composition of the final concentration of the common broth agar medium is as follows: 0.5% of glucose, 1% of peptone, 0.1% of beef extract, 0.5% of sodium chloride, 2% of agar and deionized water as a solvent, wherein the pH value is 7.4 +/-0.1.
YEPD (I) culture medium quality final concentration composition: 2% of glucose, 1% of yeast extract, 2% of peptone and deionized water as a solvent, wherein the pH is natural.
YEPD (II) culture medium quality final concentration composition: 2% of glucose, 2% of peptone and deionized water as a solvent, and the pH is natural.
Potato culture medium: 200 g/L of potato, 20 g/L of glucose, 20 g/L of agar and deionized water as a solvent, and the pH value is natural.
Example 1 screening and identification of bacterial species
1. Strain screening
The final concentration composition of the broth agar medium is as follows: peptone 1%, beef extract 0.3%, sodium chloride 0.5%, agar 2%, solvent deionized water, and pH 7.4.
Diluting sewage obtained from aerobic pond of pharmaceutical industry sewage treatment plant in Henan Tian Fang by different times (2.5 times, 25 times, 250 times, 2500 times and 25000 times respectively), and adding lincomycin to make lincomycin concentration be 0.6 g/L and 6 g/L respectively. Preparing a series of lincomycin mixtures for sewage.
20 mL of broth agar was poured into each dish while it was hot, and the plate was prepared. The lincomycin mixture was then spread onto plates and incubated at 37 ℃ for 12 h. Two strains were selected according to colony characteristics and were designated strain L5 and strain L6, respectively.
2. Identification of strains
1) Characteristics of bacterial colony
The cell morphology of strain L5 was: irregular slender tube shape with bifurcations.
The cell morphology of strain L6 was: has branched, long tubular shape intersecting with each other.
According to the microscopic observation result of the colony characteristics, L5-L6 are judged to be the mold.
2) Molecular characteristics
(1) Preparation of mycelia
And inoculating the purified bacteria into a common broth culture medium, and culturing at 28 ℃ for 36-48 h. It is best when the mycelium grows to a diameter of more than 4 mm (larger than mung bean and smaller than general soybean).
(2) Isolation and preservation of mycelia
The prepared mycelia were transferred into a 10 mL centrifuge tube and stored frozen at-20 ℃ for 24 hours. The specific operation method comprises the following steps: a5 mL pipette tip is taken, the position 6 mm away from the front end of the pipette tip (ensuring that mycelia can be sucked in and do not leak) is cut off by scissors, and the pipette tip is used for sucking the bacterial liquid and transferring the bacterial liquid into a centrifuge tube. And (4) placing the centrifugal tube filled with the bacterial liquid into a centrifugal machine for centrifugation at 5000 r/min for 20 min, and discarding the supernatant. And (3) ensuring that the height of the centrifuged mycelium is close to the 1 mL scale mark of the centrifuge tube according to the addition amount of the bacteria liquid. If the mycelium amount is insufficient after one-time centrifugation, adding the bacterial liquid into the centrifuge tube with the supernatant discarded again, and centrifuging again until enough mycelium exists.
(3) Ultrasonic method for extracting DNA
Taking out the centrifuge tube containing the frozen mycelia, adding 5mL of sterile water, thawing (heating at 40 deg.C or below), shaking, and placing into an ultrasonic instrument for ultrasonic oscillation for 10 min. After shaking, centrifugation is carried out for 10 min at 5000 r/min, the supernatant is discarded, and 3 mL of benzyl chloride extraction buffer (pH =9.0), 0.4 mL of 20% SDS solution and 2.4 mL of benzyl chloride stock solution are added. Shaking thoroughly, water bath at 50 deg.C for 1-2 h, shaking once every 10 min until the mycelium is completely dissolved (observing the dissolution state of mycelium after water bath for 1 h, and if the dissolution state and the water bath front region are not large enough, increasing the temperature to 60 deg.C and then water bath for 1 h). Sodium acetate solution (pH =5.2) 2.4 mL was added and ice-cooled for 15 min. Centrifuging at 5000 r/min for 15 min after ice bath. Taking 4 mL of the supernatant to a new centrifuge tube, adding 4 mL of isopropanol, carefully mixing uniformly, precipitating at room temperature for 20 min, and centrifuging at 5000 r/min for 10 min. The supernatant was discarded, the pellet was washed twice with 80% ethanol, and the ethanol was blown dry in a clean bench (to keep the pellet wet). The DNA precipitate was redissolved by the addition of 300 uL of 1 XTE, which was gently shaken during the dissolution. This completes the crude extraction of DNA.
And (3) putting 200 uL of the crude DNA into a 1.5 mL centrifuge tube, adding phenol/chloroform/isoamylol with the same volume, slightly reversing the mixture up and down for 30 times, centrifuging the mixture for 5 min at 12000 r/min at 18 ℃ by using a refrigerated centrifuge, and taking 100 uL of supernate into a new 1.5 mL centrifuge tube. This completes the extraction of fungal DNA.
PCR amplification and electrophoresis detection
The DNA of the fungus was amplified using 18S rRNA universal templates NS1 (5'-GTAGTCATATGCTTGTCTC-3') and NS2 (5'-GGCTGCTGGCACCAGACTTGC-3').
Operating parameters of the PCR amplification program: operating parameters of the PCR amplification program:
(94℃,5 min) + { (94℃, 30 s) + (55℃, 30 s) + (72℃, 1 min) } ×30 + (72℃, 7 min)。
and (3) carrying out electrophoretic detection on the amplified PCR product: the amplified PCR product was electrophoresed on 1% agarose gel using 1 XTE as the electrophoresis buffer under the following conditions: voltage 150V, time 20 min, taking pictures after electrophoresis, and analyzing by using specific analysis software. The PCR stock solution (not less than 10. mu.L) was sent to Hangzhou Jinzhi company for sequencing.
Identified by 18 sRNA, the strain L5 (the 18 sRNA nucleotide sequence is shown in SEQ ID NO. 1) is penicillium oxalicum: (Penicillium oxalicum) (ii) a The strain L6 (18 sRNA nucleotide sequence is shown in SEQ ID NO. 2) is penicillium chrysogenum (A)Penicillium chrysogenum)。
EXAMPLE 2 establishment of a lincomycin Standard Curve
Stationary phase: octadecylsilane chemically bonded silica (5 μm) column for liquid chromatography, 4.6 mm × 200 mm, mobile phase: 0.05M borax solution (pH adjusted to 6.1 with 85% phosphoric acid solution) and methanol were mixed (volume ratio 42: 58) at a flow rate: 1 mL/min. Column temperature: 30 ℃, detector: ultraviolet detector, detection wavelength: 214 nm.
Under the conditions, the lincomycin content (x) and the ultraviolet absorption (peak area, y) are in a linear relation within the range of 0-8.0 mg/mL, and the linear regression equation is y = 1.1013 x-0.0203, R2= 0.9997。
EXAMPLE 3 Strain culture
Respectively inoculating the strain L5 and the strain L6 selected in the example 1 into a common broth agar culture medium, culturing at 37 ℃, and performing slant preservation for later use; inoculating slant strain into common broth culture medium, sealing with 8 layers of gauze, and culturing in shaking table at 37 deg.C for 48 h at 200 r/min to obtain seed.
Example 4 selection of fermentation Medium
Since L5 is a mold, it was inoculated into a common broth medium and a potato medium, respectively (for multiple parallel experiments), cultured at 28 ℃ at 200 r/min, one bottle was periodically removed, and the mycelia were weighed. The results are shown in Table 1, and it is found that the culture effect is better when potato is used for culture, and the growth of the fungus balls is fast.
The potato culture medium formula comprises: 200 g/L of potato, 20 g/L of glucose, 20 g/L of agar and deionized water as a solvent, and the pH value is natural. The liquid loading volume is 500 mL and the liquid loading volume is 100 mL.
TABLE 1 Dry weight (g) of mycelia of L5 cultured for various periods
Incubation time (h) | General broth culture medium | Potato culture medium |
12 | 0.07 | 0.09 |
24 | 0.12 | 0.17 |
36 | 0.18 | 0.29 |
48 | 0.23 | 0.38 |
60 | 0.23 | 0.39 |
It was found that the cells were grown well by culturing them in a potato medium. The growth curve is shown in FIG. 1.
Example 5 fungal dreg degradation test
The mushroom dregs are obtained from Henan Tian prescription pharmaceutical industry Co., Ltd, and are solid wastes generated by filter pressing of lincomycin fermentation liquor, and the lincomycin content is 16.77 mg/g.
(1) Slant strains of strain L5 and strain L6 were transferred to a common broth and grown at 37 ℃ and 180 r/min for 48 hours as described in example 4; inoculating the seed solution into a potato culture medium according to the inoculation amount with the volume concentration of 10%, and culturing at 28 ℃ at 200 r/min for 48 h to obtain a fermentation liquid with the wet mycelium content of 3.5 g/mL.
(2) Respectively taking 5mL of the bacterial liquid of the two moulds in the step (1), and uniformly transferring the bacterial liquid to 10 g of sterilized lincomycin residues; meanwhile, 5mL of sterile water is uniformly connected to similarly treated mushroom dregs to be used as blank control;
(3) setting 6 days as a period, sampling and weighing every day, and calculating the bacteria dreg consumption rate. The bacteria dreg consumption rate calculation formula is as follows:
consumption rate = (M0-Mx) ÷ M0 × 100% (M0 is the weight of the mushroom residue before the start of the experiment, Mx is the weight of the mushroom residue on day x)
The bacterial strain L5 and the bacterial strain L6 can obviously reduce the amount of the cultured bacterial residues by naked eyes, and the effect of the two moulds consuming the lincomycin bacterial residues is measured by adopting a decrement weighing method. According to the determination, the consumption rates of the two moulds consuming the lincomycin residues on the sixth day are respectively 88.20% and 75.60%, and the effect is obvious (degradation curve chart 2). The strain L5 has good effect on producing acid penicillium, and is delivered to the China general microbiological culture Collection center for preservation, with the preservation number of CGMCC No. 15400.
Example 6 fungi residue supplement test
To 10 g of the fungal residue described in example 5, 5mL of the L5 bacterial solution of example 4 cultured in potato medium to a stationary phase (3.5 g wet mycelia/mL) was added, and the mixture was cultured at 28 ℃ and, after the fungal residue in the dish was consumed by the microorganisms, 10 g of fresh fungal residue was added and the culture was repeated 5 times. The mushroom dregs were found to be consumed after 5 additional times.
Sequence listing
<110> Biotechnology Ltd in Henan Taoise
<120> penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 564
<212> DNA
<213> Penicillium oxalicum (Penicillium oxalicum)
<400> 1
ttgctctaga cggggtctct gggtcacctc ccacccagtg atttatcgta ccttgttgct 60
tcggcgggcc cgcctcacgg ccgccggggg gcatccgccc ccgggcccgc gcccgccgaa 120
gacacacaaa cgaactcttg tctgaagatt gcagtctgag tacttgacta aatcagttaa 180
aactttcaac aacggatctc ttggttccgg catcgatgaa gaacgcagcg aaatgcgata 240
agtaatgtga attgcagaat tcagtgaatc atcgagtctt tgaacgcaca ttgcgccccc 300
tggtattccg gggggcatgc ctgtccgagc gtcattgctg ccctcaagca cggcttgtgt 360
gttgggctct cgccccccgc ttccgggggg cgggcccgaa aggcagcggc ggcaccgcgt 420
ccggtcctcg agcgtatggg gcttcgtcac ccgctctgta ggcccggccg gcgcccgccg 480
gcgaacacca tcaatcttaa ccaggttgac ctcggatcag gtagggatac ccgctgaact 540
taagcatatc aataagagga ggaa 564
<210> 2
<211> 857
<212> DNA
<213> Penicillium oxalicum (Penicillium oxalicum)
<400> 2
ttttattttt ctttgtgagt attctgggtc gacctcgcac ccgtgtttat cgtaccttgt 60
tgcttcggcg ggcccgcctc acggccgccg gggggcatcc gcccccgggc ccgcgcccgc 120
cgaatacaca caaacgaact cttgtctgaa gattgcagtc tgagtacttg actaaatcag 180
ttaaaacttt caacaacgga tctcttggtt ccggcatcga tgaagaacgc agcgaaatgc 240
gataagtaat gtgaattgca gaattcagtg aatcatcgag tctttgaacg cacattgcgc 300
cccctggtat tccggggggc atgcctgtcc gagcgtcatt gctgccctca agcacggctt 360
gtgtgttggg ctctcgcccc ccgcttccgg ggggcgggcc cgaaaggcag cggcggcacc 420
gcgtccggtc ctcgagcgta tggggcttcg tcacccgctc tgtaggcccg gccggcgccc 480
gccggcgaac accatcaatc ttaaccaggt tgacctcgga tcaggtaggg atacccgctg 540
aacttaagca tatcaataaa aggaggaaac gataccacgc gtttccccct ggaactccct 600
cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc 660
tagaaacgtg gcgctttctc atagctcacg ctgtaagtat ctcagttcgg tgtagtcgtt 720
cgctccaagc tgggctgtgt gcacgaaccc cccgttcacc caacccgctg ctccttatcc 780
gtatctatcg ccttgagtcc aacccgtaaa acacaactta tcgccactgc cccaacccac 840
tggtaacagg attagca 857
Claims (10)
1. Penicillium oxalicum (B)Penicillium oxalicum) L5, deposited in China general microbiological culture Collection center with the date of 20184, 8 days, preservation number CGMCC No.15400, address: xilu No.1 Hospital No. 3, Beijing, Chaoyang, North.
2. Use of the penicillium oxalicum L5 of claim 1 for degrading lincomycin bacterial residues.
3. The application according to claim 2, characterized in that the method of application is: and (3) inoculating fermentation liquor obtained by fermenting and culturing penicillium oxalicum L5 into lincomycin bacterial residues, and culturing at 25-37 ℃ to realize bacterial residue degradation.
4. The use according to claim 3, wherein the volume of the fermentation liquid is 0.1-10 mL/g based on the weight of the lincomycin residues.
5. Use according to claim 3, characterized in that the fermentation broth is prepared as follows: inoculating penicillium oxalicum L5 to a fermentation culture medium, and carrying out fermentation culture at 20-37 ℃ at a speed of 80-220 r/min for 36-54 h to obtain a fermentation liquid; the fermentation medium comprises the following components: 200 g/L of potato, 20 g/L of glucose, 20 g/L of agar and deionized water as a solvent, and the pH value is natural.
6. The use of claim 4, wherein the Penicillium oxalicum L5 is cultured by slant culture and seed culture before fermentation, and the seed solution is inoculated into the fermentation medium in an inoculum size of 2-10% by volume: inoculating penicillium oxalicum L5 to a slant culture medium, and culturing at 20-37 ℃ for 12-72 h to obtain slant bacteria; the final concentration of the slant culture medium comprises the following components by mass: 0.5-2% of glucose, 0.2-2% of peptone, 0.1-2% of beef extract, 0.1-2% of sodium chloride and 2% of agar, wherein the solvent is distilled water, and the pH value is 6-7.5; inoculating the slant thalli to a seed culture medium, and culturing at 20-37 ℃ and 80-220 r/min for 12-72 h to obtain a seed solution; the final concentration of the seed culture medium is as follows: 0.5-2% of glucose, 0.2-2% of peptone, 0.1-2% of beef extract, 0.5-2% of sodium chloride and distilled water as a solvent, wherein the pH value is 6-7.5.
7. The use according to claim 6, wherein the final concentration of the slant medium consists of: 0.5% of glucose, 1% of peptone, 0.1% of beef extract, 0.5% of NaCl, 2% of agar and distilled water as a solvent, wherein the pH value is 6-7.5.
8. Use according to claim 6, characterized in that the final concentration composition of the seed culture medium is: 0.5% of glucose, 1% of peptone, 0.1% of beef extract, 0.5% of NaCl and distilled water as a solvent, wherein the pH value is 6-7.5.
9. The use according to claim 3, wherein the lincomycin content in the lincomycin bacterial residue is 0.2-2 mg/g.
10. The use according to claim 3, wherein the mycelium content in the fermentation broth is 1 to 5 g/mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810930453.2A CN108977365B (en) | 2018-08-15 | 2018-08-15 | Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810930453.2A CN108977365B (en) | 2018-08-15 | 2018-08-15 | Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108977365A CN108977365A (en) | 2018-12-11 |
CN108977365B true CN108977365B (en) | 2021-08-27 |
Family
ID=64553850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810930453.2A Active CN108977365B (en) | 2018-08-15 | 2018-08-15 | Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108977365B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113325109A (en) * | 2017-12-29 | 2021-08-31 | 宁夏希望田野生物农业科技有限公司 | Method for detecting residual quantity of lincomycin in mushroom dregs |
CN114907996B (en) * | 2022-04-15 | 2023-07-25 | 河南金百合生物科技股份有限公司 | Klebsiella multocida BJM3, application thereof in degradation of lincomycin and microbial inoculum |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2273867A1 (en) * | 1974-06-10 | 1976-01-02 | Upjohn Co | PROCESS FOR PREPARING THE ANTIBIOTIC CALLED LINCOMYCIN |
US4150036A (en) * | 1978-06-15 | 1979-04-17 | The Upjohn Company | Antibiotic pentalenolactone derivative |
CN1228123A (en) * | 1996-08-14 | 1999-09-08 | 诺瓦提斯公司 | Peptide with inhibitory activity towards plant pathogenic fungi |
CN103266064A (en) * | 2013-01-30 | 2013-08-28 | 北京理工大学 | Penicillium oxalicum LJ302 capable of degrading chlortetracycline |
CN107267412A (en) * | 2017-05-24 | 2017-10-20 | 浙江大学 | Methylotrophic bacillus and its application |
-
2018
- 2018-08-15 CN CN201810930453.2A patent/CN108977365B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2273867A1 (en) * | 1974-06-10 | 1976-01-02 | Upjohn Co | PROCESS FOR PREPARING THE ANTIBIOTIC CALLED LINCOMYCIN |
US4150036A (en) * | 1978-06-15 | 1979-04-17 | The Upjohn Company | Antibiotic pentalenolactone derivative |
CN1228123A (en) * | 1996-08-14 | 1999-09-08 | 诺瓦提斯公司 | Peptide with inhibitory activity towards plant pathogenic fungi |
CN103266064A (en) * | 2013-01-30 | 2013-08-28 | 北京理工大学 | Penicillium oxalicum LJ302 capable of degrading chlortetracycline |
CN107267412A (en) * | 2017-05-24 | 2017-10-20 | 浙江大学 | Methylotrophic bacillus and its application |
Non-Patent Citations (2)
Title |
---|
Novel strains with superior degrading effciency for lincomycin manufacturing biowaste;Yonghong Li et al.,;《Ecotoxicology and Environmental Safety》;20201224;第209卷;第1-9页 * |
解淀粉芽胞杆菌SSY2分离鉴定及其拮抗霉菌特性研究;尹珺伊等;《动物医学进展》;20191231;第40卷(第4期);第75-79页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108977365A (en) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108048344B (en) | Two plants of deodorization bacterial strains and its application in preparation composite biological deodorant | |
CN106957807B (en) | Bacillus licheniformis strain TA65 and application thereof in promoting compost maturity | |
CN112375720B (en) | Bacillus subtilis and application thereof | |
CN107058177B (en) | Geobacillus thermosyphus denitrificus strain TB62 and application thereof in promoting compost maturity | |
JP2019156695A (en) | Composting treatment accelerator and method for producing compost | |
CN110564640B (en) | Siamese bacillus WF2019 strain for degrading aflatoxin B1 and application thereof | |
CN106978367B (en) | Bacillus ureafaciens strain TB42 and application thereof in promoting compost maturity | |
KR20180023583A (en) | Eco-microbial agent for decomposition of food waste in anaerobic conditions | |
CN108977365B (en) | Penicillium oxalicum L5 and application thereof in degradation of lincomycin bacterial residues | |
CN107879774A (en) | A kind of preparation method of biological decomposing agent | |
CN109022318B (en) | Bacillus subtilis L1 and application thereof in degrading residual lincomycin in lincomycin residues | |
CN109260940A (en) | A kind of complex microorganism deodorant and the preparation method and application thereof | |
CN108913626B (en) | Livestock and poultry manure deodorizing composite microbial inoculum and preparation method thereof | |
CN113481130A (en) | High-temperature-resistant kitchen waste decomposing composite microbial agent and preparation method and application thereof | |
CN112251357A (en) | Method for screening livestock and poultry manure fermentation microbial inoculum | |
CN114907996B (en) | Klebsiella multocida BJM3, application thereof in degradation of lincomycin and microbial inoculum | |
CN109652328B (en) | Composite microorganism live bacteria preparation and application thereof in high-concentration pig-raising wastewater | |
CN116590164A (en) | Kluyveromyces pichia pastoris FJY-4 strain and application thereof | |
CN105087419A (en) | Application of bacillus subtilis in treating total nitrogen in tannery wastewater | |
KR102430375B1 (en) | Bacillus velezensis L001 strain having odor removal actibity, Composition for removing or reducing odor comprising the same, and Method for removing or reducing odor using the same | |
CN115141770A (en) | Bacillus tequilensis H1 capable of degrading COD in livestock wastewater and application thereof | |
CN113862169A (en) | Bacillus belgii and application thereof in feather degradation | |
JP2011240328A (en) | Method for treating object to be treated using microorganism | |
CN104962502A (en) | Composite microbial inoculant for sludge treatment and preparation method thereof | |
CN106479910B (en) | Lactic acid-producing streptococcus bovis and separation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210723 Address after: 450001 No. 100 science Avenue, hi tech Zone, Henan, Zhengzhou Applicant after: Zhengzhou University Address before: 450001 No. 106, floor 1, block B, No. 7, Dongqing street, high tech Industrial Development Zone, Zhengzhou City, Henan Province Applicant before: HENAN DAODI BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |